Adacel: all 28 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Tdap Vaccine Safety for Plasma DonorsCompletedNCT04142983Phase 2/3Results posted
- Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy SubjectsTerminatedNCT02992418Phase 3Results posted
- Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy AdolescentsCompletedNCT02199691Phase 2Results posted
- Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years OldCompletedNCT02089347Phase 3Results posted
- Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in ChinaCompletedNCT01933776Phase 1Results posted
- Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in AdolescentsCompletedNCT01689324Phase 1/2Results posted
- Immunogenicity of Adacel® and BOOSTRIX® Vaccines in AdolescentsCompletedNCT01629589Phase 4Results posted
- Study of Adacel® Vaccine Administered to Persons 10 Years of AgeCompletedNCT01311557Phase 4Results posted
- Post Marketing Surveillance for ADACEL™ in South KoreaCompletedNCT01137435Phase 4Results posted
- A Study to Assess the Safety of Adacel® VaccineCompletedNCT01040052Phase 3Results posted
- A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)CompletedNCT00988884Phase 3Results posted
- Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap VaccineCompletedNCT00777257Phase 4Results posted
- Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous DoseCompletedNCT00712959Phase 4Results posted
- Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of AgeCompletedNCT00467519Phase 3Results posted
- A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and OlderCompletedNCT00457249Phase 4Results posted
- Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® VaccineCompletedNCT00347958Phase 4Results posted
- Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 YearsCompletedNCT00346073Phase 3Results posted
- Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)CompletedNCT00325130Phase 3Results posted
- Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®CompletedNCT00319553Phase 4Results posted
- Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis VaccineCompletedNCT00304265Phase 4Results posted
- Immunogenicity and Safety of ADACEL™ as Fifth Dose in TaiwanCompletedNCT00258908Phase 3Results posted
- Maternal Determinants of Infant Immunity to PertussisCompletedNCT05856396Phase 4
- Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant WomenCompletedNCT05264662Phase 4
- Adacel® Booster Vaccination for CMI Assay DevelopmentCompletedNCT04543669Phase 4
- Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.CompletedNCT01993173Phase 3
- Immunogenicity and Safety of an Acellular DPT Vaccine During PregnancyCompletedNCT01445743Phase 2
- An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine BoosterStatus unknownNCT00870350Phase 4
- The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant RecipientsStatus unknownNCT00336115Phase 4